Infectologia

Relatório OMS | Mais casos de malária e mortes em 2020 associados com interrupções no cuidado causadas pela COVID-19.

7 Dez, 2021 | 11:38h

Comunicado de imprensa: More malaria cases and deaths in 2020 linked to COVID-19 disruptions – World Health Organization

Relatório: World Malaria Report 2021 – World Health Organization

Comentários:

More people died of malaria in 2020 than in 2019. Here’s why – NPR

Malaria kills 180,000 more people annually than previously thought, says WHO – The Guardian

 

Comentário no Twitter (fio – clique para saber mais)

#COVID19 pandemic has disrupted #malaria services, leading to a marked increase in cases and deaths: 14 million more cases in 2020 compared to 2019, and 69,000 more deaths – new report.
➡️https://t.co/M9sNo2Pn4u #EndMalaria pic.twitter.com/g6MKFVpQKf

— World Health Organization (WHO) (@WHO) December 6, 2021

 

---

Diretriz IDSA sobre o tratamento de infecções por enterobactérias produtoras de AmpC betalactamase, Acinetobacter baumannii resistente a carbapenêmicos e Stenotrophomonas maltophilia.

7 Dez, 2021 | 11:36h

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections – Clinical Infectious Diseases

---

Revisão clínica | Tratamento da pneumonia em pacientes criticamente doentes.

7 Dez, 2021 | 11:33h

Management of pneumonia in critically ill patients – The BMJ

---

Estudo randomizado | Maribavir para infecções por citomegalovírus refratárias com ou sem resistência pós-transplante.

7 Dez, 2021 | 11:29h

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial – Clinical Infectious Diseases

---

Revisão sistemática | Práticas atuais de tratamento da infecção por citomegalovírus materna e congênita durante a gestação após uma infecção primária ocorrida no primeiro trimestre da gestação.

7 Dez, 2021 | 11:28h

Current practices of management of maternal and congenital Cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: Systematic review – PLOS One

---

Estudo no Reino Unido mostra que 6 diferentes reforços contra COVID-19 são seguros e aumentam a imunidade quando dados depois de 2 doses de vacinas da AstraZeneca ou Pfizer-BioNTech, com variações significativas nas respostas imunes.

6 Dez, 2021 | 16:27h

Comunicado de imprensa: Six different COVID-19 boosters are safe and increase immunity when given after two doses of AstraZeneca or Pfizer-BioNTech, with large variations in immune responses, UK trial shows – The Lancet

Estudo original: Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial – The Lancet

Comentários:

Six different COVID-19 boosters induce variable immune response – CIDRAP

Covid booster shots significantly strengthen immunity, trial finds – The Guardian

Expert reaction to COV-BOOST study investigating safety and immunogenicity of seven COVID-19 vaccines as a third dose following two doses of either Oxford-AstraZeneca or Pfizer – Science Media Centre

 

Comentário no Twitter

NEW—Six different COVID-19 boosters are safe and increase immunity when given after two doses of #AstraZeneca or #Pfizer-BioNTech, with large variations in immune responses, UK trial shows. https://t.co/ktUp1m2Rsb pic.twitter.com/wlwxcLYDm1

— The Lancet (@TheLancet) December 2, 2021

 

---

Dados preliminares da África do Sul indicam que a variante Ômicron pode causar Covid menos grave, porém mais pesquisas são necessárias.

6 Dez, 2021 | 16:23h

Early data from South Africa hints Omicron variant may cause less severe Covid, but more research is needed – STAT

Relatório original: Tshwane District Omicron Variant Patient Profile – Early Features

---

Dados europeus sobre a variante Ômicron: dos 109 casos confirmados até agora, todos sobre os quais há informação disponível quanto à gravidade foram assintomáticos ou leves.

6 Dez, 2021 | 16:22h

Epidemiological update: Omicron variant of concern (VOC) – data as of 3 December 2021 (12.00) – European Centre for Disease Prevention and Control

 

Comentário no Twitter:

EUROPEAN EQUIVALENT OF CDC AS OF THIS AM: "All cases [of Omicron] for which there is available information on severity were either asymptomatic or mild. No deaths have been reported among these cases so far.". But let's keep on watching. https://t.co/3jHm4Wezi8

— Monica Gandhi MD, MPH (@MonicaGandhi9) December 3, 2021

 

---

OMS ainda não tem relatos sobre mortes por Covid causadas pela variante Ômicron.

6 Dez, 2021 | 16:21h

WHO has no reports yet of Omicron Covid deaths – MedicalXpress

 

Comentário no Twitter

Despite #OmnicronVariant's global spread, the WHO says there are no Omicron deaths so far. The agency warns it may take weeks to determine how infectious the variant is, whether it causes more severe illness & how effective antivirals & vaccines are https://t.co/NSN6Ysf3gc pic.twitter.com/Wnp90HvUng

— delthia ricks 🔬 (@DelthiaRicks) December 4, 2021

 

---

Fauci afirma que os relatórios preliminares sobre a variante Ômicron são encorajadores – “Até o momento, não parece haver um alto nível de gravidade.”

6 Dez, 2021 | 16:19h

Fauci says Omicron variant doesn’t look severe, but ‘got to be careful’ – Associated Press

---